Peter Vozzo | Westwicke, Investor Relations |
Jack Khattar | Chief Executive Officer |
Tim Dec | Chief Financial Officer |
David Steinberg | Jefferies |
Ken Cacciatore | Cowen |
David Amsellem | Piper Sandler |
Annabel Samimy | Stifel |
Good afternoon, and welcome to Supernus Pharmaceuticals' Third Quarter 2021 Financial Results Conference Call [Operator Instructions].
As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Vozzo of Westwicke Investor Relations representative for Supernus pharmaceuticals.
You may begin.
Thank you, Nika.